11.6 Confidential Site, Midwest, U.S.
Contact: Barrie Selcoe
Organization: CH2M
Email: [email protected]
11.6.1 Site Description and Conceptual Site Model
The site is a mixed residential/commercial neighborhood in the Midwest. Historical industrial facilities operated in the area for approximately 50 years.
An in vitro bioaccessibility (IVBA) study for lead was conducted on site soil with the hope of observing lower relative bioavailability (RBA) than the USEPA default value of 60%. Given the large size of the neighborhood, the hope was that site-specific RBA data would allow calculation of a higher soil cleanup level than the default soil cleanup level (based on the default RBA). After considering the site-specific cleanup level calculations, the project manager decided not to use the site-specific cleanup levels, but to use USEPA’s default residential cleanup level because of its precedence at other sites.
The focus of the study was to evaluate the oral bioavailability of lead in soil on numerous residential properties in an area that had been previously sampled for lead. The sample locations and depth intervals submitted for bioavailability testing were chosen to provide a range of lead concentrations.
A five-point composite of soil was collected at each of 31 residential locations (USEPA 2003c). The five-point composite was collected to be representative of the residential property as a whole (including soil from the front, back, and side yards of each property). Samples were collected from depths of 0 to 6 inches, 6 to 12 inches, or both, and were analyzed for total lead and bioaccessible lead. Of the samples collected, 19 samples were submitted for lead IVBA testing. Total lead concentrations in the samples submitted for IVBA testing ranged from 224 to 1249 mg/kg. The local background level of lead at the site was not established.
Information on soil type and soil chemistry was not provided. Exposure to site soils is due to residential land use.
11.6.2 Methodology Used for Evaluating Bioavailability
11.6.3 Application of Bioavailability to Risk Assessment and Effect on Site Decisions